Please visit our site at http://www.cw15kxvo.com/story/20244692/pharmaessentia-acquires-certain-asian-rights-for-dermatology-preparations-of-kinex-pharmaceuticals-promising-novel-dual-srcpretubulin-inhibitor-kx01.